Hemispherx -First Product Approved for ME/CFS Indication Anywhere in the World - Breakthrough Approval in Latin America and the European Union - Stock Watch Index

Hemispherx -First Product Approved for ME/CFS Indication Anywhere in the World – Breakthrough Approval in Latin America and the European Union

August 26, 2016

August 26, 2016 (PPI-OT) / PRNewswire / Asianet-Pakistan: Following is the text of press release issued by HemispherxBiopharma Quote HemispherxBiopharma, Inc. (NYSE:HEB) (the “Company” or “Hemispherx”), announced that it has received approval of its New Drug Application (NDA) from AdministracionNacional de Medicamentos, Alimentos y TecnologiaMedica (ANMAT) for commercial sale of rintatolimod (U.S. tradename: AmpligenÂ®) in the…

Search

RECENT PRESS RELEASES

Meta Faces Multibillion-Dollar Lawsuit As Supreme Court Dismisses Appeal In Cambridge Analytica Data Scandal – Alibaba Gr Hldgs (NYSE:BABA), Meta Platforms (NASDAQ:META)

SWI Editorial Staff2024-11-23T06:49:34-08:00November 23, 2024|

How to set up your Ray-Ban Meta smart glasses

SWI Editorial Staff2024-11-23T06:49:32-08:00November 23, 2024|

The Best Black Friday Meta Quest Deal Just Dropped: Buy a Quest 3S, Get a $75 Best Buy Gift Card

SWI Editorial Staff2024-11-23T06:49:31-08:00November 23, 2024|

Meta fires several workers who were paid six-figure salaries for abusing a benefit the company gave them

SWI Editorial Staff2024-11-23T06:49:29-08:00November 23, 2024|

Meta loses ground to Bluesky as users abandon Elon Musk’s X

SWI Editorial Staff2024-11-23T06:49:26-08:00November 23, 2024|

I’m an engineer who left Silicon Valley for Philadelphia. I was worried about leaving the tech hub, but I love Philly’s lower cost of living.

SWI Editorial Staff2024-11-23T06:48:05-08:00November 23, 2024|

Related Post